These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20977368)

  • 1. Aqueous and vitreous penetration of linezolid and levofloxacin after oral administration.
    George JM; Fiscella R; Blair M; Rodvold K; Ulanski L; Stokes J; Blair N; Pontiggia L
    J Ocul Pharmacol Ther; 2010 Dec; 26(6):579-86. PubMed ID: 20977368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aqueous and vitreous penetration of linezolid (Zyvox) after oral administration.
    Fiscella RG; Lai WW; Buerk B; Khan M; Rodvold KA; Pulido JS; Labib S; Shapiro MJ; Blair NP
    Ophthalmology; 2004 Jun; 111(6):1191-5. PubMed ID: 15177970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aqueous and vitreous penetration of levofloxacin after oral administration.
    Fiscella RG; Nguyen TK; Cwik MJ; Phillpotts BA; Friedlander SM; Alter DC; Shapiro MJ; Blair NP; Gieser JP
    Ophthalmology; 1999 Dec; 106(12):2286-90. PubMed ID: 10599658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of linezolid in human non-inflamed vitreous after systemic administration.
    Horcajada JP; Atienza R; Sarasa M; Soy D; Adán A; Mensa J
    J Antimicrob Chemother; 2009 Mar; 63(3):550-2. PubMed ID: 19109336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular penetration of linezolid after oral administration in rabbits.
    Saleh M; Lefevre S; Bourcier T; Prevost G; Gaucher D; Speeg-Schatz C; Jehl F
    J Ocul Pharmacol Ther; 2011 Jun; 27(3):243-6. PubMed ID: 21510740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aqueous and vitreous penetration of levofloxacin after topical and/or oral administration.
    Sakamoto H; Sakamoto M; Hata Y; Kubota T; Ishibashi T
    Eur J Ophthalmol; 2007; 17(3):372-6. PubMed ID: 17534819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human vitreous distribution of linezolid after a single oral dose.
    Ciulla TA; Comer GM; Peloquin C; Wheeler J
    Retina; 2005; 25(5):619-24. PubMed ID: 16077360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient penetration into aqueous humor by administration of oral and topical levofloxacin.
    Ishida M; Kataoka T; Niwa K; Iwaki M; Zako M
    J Ocul Pharmacol Ther; 2011 Jun; 27(3):247-50. PubMed ID: 21548793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linezolid, levofloxacin, and vancomycin against vancomycin-tolerant and fluoroquinolone-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model.
    Cha R; Akins RL; Rybak MJ
    Pharmacotherapy; 2003 Dec; 23(12):1531-7. PubMed ID: 14695032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration of topically applied levofloxacin 0.5% and ofloxacin 0.3% into the vitreous of the non-inflamed human eye.
    Puustjärvi T; Teräsvirta M; Nurmenniemi P; Lokkila J; Uusitalo H
    Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1633-7. PubMed ID: 16715252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitreous and Aqueous Penetration of Orally Administered Trimethoprim-Sulfamethoxazole Combination in Humans.
    Feiz V; Nijm L; Glickman RD; Morse LS; Telander DG; Park SS; Polage CR; Christiansen SM; Moshirfar M
    Cornea; 2013 Oct; 32(10):1315-20. PubMed ID: 23928948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular penetration of topically applied linezolid in a rabbit model.
    Saleh M; Jehl F; Dory A; Lefevre S; Prevost G; Gaucher D; Sauer A; Speeg-Schatz C; Bourcier T
    J Cataract Refract Surg; 2010 Mar; 36(3):488-92. PubMed ID: 20202550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of linezolid in the non-inflamed human eye.
    Prydal JI; Jenkins DR; Lovering A; Watts A
    Br J Ophthalmol; 2005 Nov; 89(11):1418-9. PubMed ID: 16234443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levofloxacin disposition over time in aqueous humor of patients undergoing cataract surgery.
    Pea F; Ferrari E; Pavan F; Roman-Pognuz D; Bandello F; Furlanut M
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2554-7. PubMed ID: 15917572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates.
    Harper T; Miller D; Flynn HW
    Ophthalmology; 2007 May; 114(5):871-5. PubMed ID: 17383732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.
    Murillo O; Doménech A; Garcia A; Tubau F; Cabellos C; Gudiol F; Ariza J
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4011-7. PubMed ID: 17015630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis.
    Stein GE; Schooley SL; Peloquin CA; Kak V; Havlichek DH; Citron DM; Tyrrell KL; Goldstein EJ
    Ann Pharmacother; 2005 Mar; 39(3):427-32. PubMed ID: 15701775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penetration of ofloxacin in human aqueous and vitreous humors following oral and topical administration.
    Cekic O; Batman C; Yasar U; Basci NE; Bozkurt A; Kayaalp SO
    Retina; 1998; 18(6):521-5. PubMed ID: 9869460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue penetration and antimicrobial activity of standard- and high-dose trimethoprim/sulfamethoxazole and linezolid in patients with diabetic foot infection.
    Stein GE; Throckmorton JK; Scharmen AE; Weiss WJ; Prokai L; Smith CL; Havlichek DH
    J Antimicrob Chemother; 2013 Dec; 68(12):2852-8. PubMed ID: 23873647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.
    Adembri C; Fallani S; Cassetta MI; Arrigucci S; Ottaviano A; Pecile P; Mazzei T; De Gaudio R; Novelli A
    Int J Antimicrob Agents; 2008 Feb; 31(2):122-9. PubMed ID: 18055183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.